Published Date: 22 Apr 2025
Overall cancer mortality rates declined from 2001 through 2022, while cancer incidence rates decreased from 2001 through 2013 and stabilized through 2021, according to the 2024 Annual Report to the Nation on the Status of ...
Read Full NewsPeople with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.
Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.
Nearly half of new colorectal cancer cases now occur in people younger than age 65 years, highlighting the need for earlier screening and better symptom awareness.
Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.
1.
'Converging' Evidence of Link Between Air Pollution and Breast Cancer
2.
Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.
3.
Prostate cancer Q&A: Improving detection and reducing overtreatment
4.
New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.
5.
Cancer patients want financial screening early in care, study finds
1.
Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders
2.
The Future of Hemophilia Treatment: Long-Acting Therapies and Gene Editing
3.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
4.
Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits
5.
The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
4.
Navigating the Complexities of Ph Negative ALL - Part XIII
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation